Insomnia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 or above, gender not limited. 2.Voluntarily participate in this study and sign a written informed consent form. 3.Have a routine health check-up at the physical examination center. 4.Insomnia: PSQI total score >=7 points. 5.Be able to operate the equipment correctly and complete the questionnaire. 6.Agree to complete at least 20 treatments (compliance rate >=70%).
Exclusion criteria
Exclusion criteria: 1.According to the researchers' judgment, his insomnia is mainly caused by uncontrolled severe anxiety disorders, depression and other mental illnesses, or by substance abuse (such as alcohol and drugs). 2.Those who have implanted cardiac pacemakers, Implantable Cardioverter defibrillators (ICDs), or other electronic implants in their bodies. 3.There is skin damage, infection, malignant tumor or acute inflammation at the treatment site. 4.People suffering from severe cardiovascular diseases (such as unstable angina pectoris, severe arrhythmia), cerebrovascular diseases, liver and kidney dysfunction, or uncontrolled epilepsy and other serious physical diseases. 5.Pain-related diseases with a clear diagnosis that require special medical intervention, such as pain related to malignant tumors, acute traumatic pain, and the active stage of rheumatic immune diseases, etc. 6.Pregnant or lactating women. 7.Currently participating in other clinical trials or having used other experimental treatments within the past month. 8.The researcher believes that there are any other circumstances that make one unsuitable to participate in this study. 9.During the 10-week intervention period, pay attention to contraception.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Achieved therapeutic response at 10 weeks; | — |
Countries
China
Contacts
Peking University Shenzhen Hospital